Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC - Top-Institutions - MDSpire

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC

  • By

  • Naïla Benkalfate

  • Ghazi Hadjamara

  • Caroline Petorin

  • Magaly Zappa

  • Aimable Habonimana

  • Dufens Pierre Louis

  • Anne-Laure Chene

  • Jean-Patrick Clarke

  • Renan Liberge

  • Kinane Drak Alsibai

  • Claire Defrance

  • Barbara Pistilli

  • Baptiste Boulet

  • Soraya Benguerfi

  • Houari Aissaoui

  • May 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    University of Milan
    University of Milan

    Milan, Lombardy

    Key Differentiators

    • Oncology

  • #3

    Barts Cancer Institute at Queen Mary University
    Barts Cancer Institute at Queen Mary University

    London, England

    Key Differentiators

    • Oncology

  • #4

    European Institute of Oncology
    European Institute of Oncology

    Milan, Lombardy

    Key Differentiators

    • Oncology

Original Source(s)

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC

  • by Naïla Benkalfate, Ghazi Hadjamara, Caroline Petorin, Magaly Zappa, Aimable Habonimana, Dufens Pierre Louis, Anne-Laure Chene, Jean-Patrick Clarke, Renan Liberge, Kinane Drak Alsibai, Claire Defrance, Barbara Pistilli, Baptiste Boulet, Soraya Benguerfi, Houari Aissaoui

  • May 22, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report